Price loading...

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

Price data last checked 102 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in India
98% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Macular Degeneration Treatments in the United States
98% match

The 2023-2028 Outlook for Macular Degeneration Treatments in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States
98% match

The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States
98% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Dry Eye Syndrome Treatments in the United States
98% match

The 2023-2028 Outlook for Dry Eye Syndrome Treatments in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Vision Care in the United States
97% match

The 2023-2028 Outlook for Vision Care in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Peripheral Neuropathy Treatments in the United States
97% match

The 2023-2028 Outlook for Peripheral Neuropathy Treatments in the United States

£520.00 21 Apr 2026
The 2023-2028 Outlook for Eye Allergy Treatments in the United States
97% match

The 2023-2028 Outlook for Eye Allergy Treatments in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Optical Goods and Eye Care Products in the United States
97% match

The 2023-2028 Outlook for Optical Goods and Eye Care Products in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
97% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States
97% match

The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
97% match

The 2023-2028 Outlook for Amyloidosis Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Diabetic Neuropathy in the United States
97% match

The 2023-2028 Outlook for Diabetic Neuropathy in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States
97% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Glass Lens Vision Care in the United States
97% match

The 2023-2028 Outlook for Glass Lens Vision Care in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Neurostimulation Devices in the United States
97% match

The 2023-2028 Outlook for Neurostimulation Devices in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States
97% match

The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States

£520.00 01 Feb 2026
The 2023-2028 World Outlook for Dry Eye Syndrome Treatments
97% match

The 2023-2028 World Outlook for Dry Eye Syndrome Treatments

£795.00 24 Jan 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
97% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
97% match

The 2023-2028 Outlook for Motion Sickness Treatments in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for External Neurostimulation in the United States
97% match

The 2023-2028 Outlook for External Neurostimulation in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Diabetes Treatments in the United States
97% match

The 2023-2028 Outlook for Diabetes Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Non-Opioid Pain Treatments in the United States
97% match

The 2023-2028 Outlook for Non-Opioid Pain Treatments in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Eyeglass Lenses in the United States
96% match

The 2023-2028 Outlook for Eyeglass Lenses in the United States

£520.00 23 Jan 2026